1. Home
  2. NVAX vs UAMY Comparison

NVAX vs UAMY Comparison

Compare NVAX & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

N/A

Current Price

$9.40

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Logo United States Antimony Corporation

UAMY

United States Antimony Corporation

N/A

Current Price

$7.97

Market Cap

1.2B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
NVAX
UAMY
Founded
1987
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
1996
1997

Fundamental Metrics

Financial Performance
Metric
NVAX
UAMY
Price
$9.40
$7.97
Analyst Decision
Hold
Strong Buy
Analyst Count
9
5
Target Price
$10.78
$5.69
AVG Volume (30 Days)
3.8M
12.9M
Earning Date
04-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
77.26
66.67
EPS
2.53
N/A
Revenue
$682,162,000.00
$14,937,962.00
Revenue This Year
$58.91
$164.09
Revenue Next Year
N/A
$218.34
P/E Ratio
$3.68
N/A
Revenue Growth
N/A
71.84
52 Week Low
$5.01
$1.21
52 Week High
$10.63
$19.71

Technical Indicators

Market Signals
Indicator
NVAX
UAMY
Relative Strength Index (RSI) 60.93 52.69
Support Level $8.01 $6.57
Resistance Level $10.42 $8.38
Average True Range (ATR) 0.51 0.84
MACD 0.04 -0.07
Stochastic Oscillator 93.41 52.03

Price Performance

Historical Comparison
NVAX
UAMY

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

Share on Social Networks: